Literature DB >> 3062329

Experimental chronic pulmonary infection in mice caused by Klebsiella pneumoniae.

Y Iizawa1, T Nishi, M Kondo, A Imada.   

Abstract

Examination of mouse strain differences in susceptibility to experimental respiratory tract infection with Klebsiella pneumoniae 27 revealed that a chronic pulmonary infection model could be established using CBA/J mice. After 6 X 10(5) colony-forming units of K. pneumoniae 27 were inoculated into the lung, the bacterial counts in the lungs changed with time showing four different phases: initial decrease, regrowth, steady-state, and final increase leading to death. Throughout the course of the infection, the challenge bacteria were isolated mainly from the respiratory organs. Pulmonary gross lesions appeared on day 2 after infection and persisted thereafter. Lobar consolidation was the primary lesion and occurred mainly in the anterior and middle lobes of the right lung, and the median lobe. Mice began to die from 4 weeks after aerosol exposure. This model may be useful for investigating the pathogenesis of chronic pulmonary infection by Klebsiella and its therapy.

Entities:  

Mesh:

Year:  1988        PMID: 3062329     DOI: 10.1111/j.1348-0421.1988.tb01451.x

Source DB:  PubMed          Journal:  Microbiol Immunol        ISSN: 0385-5600            Impact factor:   1.955


  5 in total

1.  Bacterial infection modulated by glucan: a search for the host defense potentiation mechanisms.

Authors:  J Franĕk; J Malina; H Krátká
Journal:  Folia Microbiol (Praha)       Date:  1992       Impact factor: 2.099

2.  Informative value of a mouse model of Klebsiella pneumoniae infection used as a host-resistance assay.

Authors:  J Malina; J Hofmann; J Franĕk
Journal:  Folia Microbiol (Praha)       Date:  1991       Impact factor: 2.099

3.  Efficacy of TAK-457, a novel intravenous triazole, against invasive pulmonary Aspergillosis in neutropenic mice.

Authors:  Ryogo Hayashi; Naomi Kitamoto; Yuji Iizawa; Takashi Ichikawa; Katsumi Itoh; Tomoyuki Kitazaki; Kenji Okonogi
Journal:  Antimicrob Agents Chemother       Date:  2002-02       Impact factor: 5.191

4.  Therapeutic effect of cefozopran (SCE-2787), a new parenteral cephalosporin, against experimental infections in mice.

Authors:  Y Iizawa; K Okonogi; R Hayashi; T Iwahi; T Yamazaki; A Imada
Journal:  Antimicrob Agents Chemother       Date:  1993-01       Impact factor: 5.191

5.  The ability of airborne Klebsiella pneumoniae to colonize mouse lungs.

Authors:  N J Bolister; H E Johnson; C M Wathes
Journal:  Epidemiol Infect       Date:  1992-08       Impact factor: 2.451

  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.